Alnylam Pharmaceuticals
ALNY
#856
Rank
ยฃ22.20 B
Marketcap
ยฃ165.96
Share price
1.24%
Change (1 day)
-47.56%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company